Gene Transfer
2-Amine is major bystander metabolite when CB 1954 is activated by NTR in tumors
Published in Gene Therapy Weekly, June 24th, 2004
"An important feature of gene-directed enzyme-prodrug therapy is that prodrug activation can provide diffusible cytotoxic metabolites capable of generating a local bystander effect in tumors. Activation of the aziridinyl dinitrobenzamide CB 1954 by E. coli nitroreductase (NTR) provides a bystander effect assumed to be due to the potently cytotoxic 4-hydroxylamine metabolite," scientists in New Zealand report.
"We show that there are four cytotoxic extracellular metabolites of CB 1954 in cultures of NTR-expressing tumor cells (the 2- and 4-hydroxylamines and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2004-06-24)
More Articles from Gene Therapy Weekly
- Gene Induction
Inducible promoters aid gene expression in head and neck cancer cells - Gene Transfer
High-capacity hybrid viral vectors garner transduction stability - Genetic Engineering
Stem cell factor gene-modified natural killer cells overwhelm tumor cells - Metastasis
Antisense oligonucleotides diminish breast cancer cell migration - Tumor Suppression
Adenoviruses bearing gfp-zeocin fusion cassettes select p53-deficient cells - Bioengineering
2'-O-methyl- groups stabilize the binding of phosphorothioate antisense ODNs - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
